A new approach, published in “Cell Reports,” to regenerate inner ear sensory hair cells is said to lay the groundwork for treating chronic noise-induced hearing loss by the company, Frequency Therapeutics, and its co-founders who are drawing on research from Brigham and Women's Hospital (BWH), Harvard Medical School, Mass Eye and Ear Infirmary, and MIT. The program is expected to progress to into human clinical trials within the next 18 months.
Ménière's disease is manifested in sudden onset of severe dizziness (vertigo) attacks, hearing impairment, and tinnitus. Accumulation of excess fluid in the inner ear is thought to cause the disorder, from which an estimated 615,000 people in the United States suffer.
ChatableApps announced the launch of “the world’s first universal hearing aid, using neuroscience-led artificial intelligence to enable those suffering from hearing loss to hear one-to-one conversations clearly, using an everyday smartphone and a standard pair of earbuds.”
Fair housing laws provide distinct protections for people who are deaf or hard of hearing. These consumers have the right to interpreters or other aids to ensure they can effectively communicate with housing providers.